S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

IMAB

I MAB (IMAB)

I MAB

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
06/06/2024	6:14AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
06/06/2024	6:00AM	PR Newswire (US)	I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	NASDAQ:IMAB	I MAB
06/05/2024	6:11AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
06/05/2024	6:00AM	PR Newswire (US)	I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	NASDAQ:IMAB	I MAB
05/30/2024	4:33PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IMAB	I MAB
05/23/2024	4:11PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
05/23/2024	4:05PM	GlobeNewswire Inc.	I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024	NASDAQ:IMAB	I MAB
05/22/2024	6:00AM	PR Newswire (US)	I-Mab to Participate at the Jefferies Global Healthcare Conference	NASDAQ:IMAB	I MAB
04/30/2024	6:00AM	PR Newswire (US)	I-MAB Filed 2023 Annual Report on Form 20-F	NASDAQ:IMAB	I MAB
04/05/2024	6:00AM	PR Newswire (US)	I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:IMAB	I MAB
04/02/2024	3:01PM	PR Newswire (US)	I-Mab Announces Closing of the Divestiture of Business Operations in China	NASDAQ:IMAB	I MAB
03/14/2024	4:00PM	PR Newswire (US)	I-Mab Reports Full Year 2023 Financial Results and Business Update	NASDAQ:IMAB	I MAB
02/09/2024	3:01PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IMAB	I MAB
02/08/2024	5:07AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
02/07/2024	5:52AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
02/07/2024	5:00AM	PR Newswire (US)	I-Mab Signs Agreement to Divest its Assets and Business Operations in China	NASDAQ:IMAB	I MAB
02/06/2024	7:55PM	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IMAB	I MAB
02/06/2024	5:34AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
01/05/2024	5:21AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
01/02/2024	4:08PM	Dow Jones News	ADRs Slump; FLJ Group Declines 21%	NASDAQ:IMAB	I MAB
12/29/2023	5:12AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
12/26/2023	5:22AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
12/01/2023	1:41PM	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:IMAB	I MAB
11/16/2023	5:43AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
11/06/2023	7:00AM	PR Newswire (US)	I-Mab Announces Participation at Jefferies and Piper Conferences in November	NASDAQ:IMAB	I MAB
11/02/2023	7:00AM	PR Newswire (US)	Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)	NASDAQ:IMAB	I MAB
11/01/2023	7:00AM	PR Newswire (US)	I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023	NASDAQ:IMAB	I MAB
10/16/2023	7:00AM	PR Newswire (US)	I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023	NASDAQ:IMAB	I MAB
10/10/2023	10:04AM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
10/10/2023	7:24AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 Next >>

FOXO Technologies

Decentral Life (PK)

Bioelectronics (PK)

NioCorp Developments

Voip Pal Com (QB)

Digital Brand Media and ... (PK)

Trump Media and Technology

SMC Entertainment (PK)

Anavex Life Sciences

ERHC Energy (CE)

Elite Pharmaceuticals (QB)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions